Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 7/2000

01-07-2000

Subsite-specific risk factors for hypopharyngeal and esophageal cancer (Japan)

Authors: T. Takezaki, M. Shinoda, S. Hatooka, Y. Hasegawa, S. Nakamura, K. Hirose, M. Inoue, N. Hamajima, T. Kuroishi, H. Matsuura, K. Tajima

Published in: Cancer Causes & Control | Issue 7/2000

Login to get access
Metadata
Title
Subsite-specific risk factors for hypopharyngeal and esophageal cancer (Japan)
Authors
T. Takezaki
M. Shinoda
S. Hatooka
Y. Hasegawa
S. Nakamura
K. Hirose
M. Inoue
N. Hamajima
T. Kuroishi
H. Matsuura
K. Tajima
Publication date
01-07-2000
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 7/2000
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1008909129756

Other articles of this Issue 7/2000

Cancer Causes & Control 7/2000 Go to the issue

OriginalPaper

Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States)

OriginalPaper

Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States)

OriginalPaper

Employment as butcher and cancer risk in a record-linkage study from Sweden

OriginalPaper

Breast feeding practices in relation to endometrial cancer risk, USA

OriginalPaper

A prospective study of lifestyle factors and the risk of pancreatic cancer in Nord-Trøndelag, Norway

OriginalPaper

Prospective investigation of emotional control and cancer risk in men (the Zutphen Elderly Study) (The Netherlands)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits